Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Correspondence

Blood Group Discrepancy-First Sign of Autoimmune Hemolytic Anemia after Hematopoietic Stem Cell Transplantation in a Child

Authors: Suvro Sankha Datta, Mahua Reddy, Sabita Basu, Shekhar Krishnan

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

A 12-year-old male child was presented in the emergency with features of anemia and mild icterus on day+67 of HSCT. The child was suffering from Fanconi anemia and undergone HSCT from ABO-matched, fully HLA matched sibling donor. The diagnosis of mixed type AIHA due to cytomegalovirus reactivation was made in the immunohematology laboratory and blood group discrepancy was the first sign of AIHA in this patient. Though the cold agglutinin titer was not significant but the clinical symptoms and laboratory evidences were suggestive of significant hemolysis due to underlying IgG autoantibody. In addition the high complement avidity of IgM autoantibody might also be a contributing factor for clinically significant hemolysis in this case. The patient was successfully treated with phenotype matched blood transfusion, rituximab and oral steroid therapy.
Literature
1.
2.
go back to reference Wang M, Wang W, Abeywardane A et al (2015) Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King’s College Hospital. Biol Blood Marrow Transplant 21(1):60–66CrossRefPubMed Wang M, Wang W, Abeywardane A et al (2015) Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King’s College Hospital. Biol Blood Marrow Transplant 21(1):60–66CrossRefPubMed
3.
go back to reference Ahmed I, Teruya J, Murray-Krezan C, Krance R (2015) The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post second hematopoietic stem cell transplant. Pediatr Transplant 19(4):391–398CrossRefPubMedPubMedCentral Ahmed I, Teruya J, Murray-Krezan C, Krance R (2015) The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post second hematopoietic stem cell transplant. Pediatr Transplant 19(4):391–398CrossRefPubMedPubMedCentral
4.
go back to reference Faraci M, Zecca M, Pillon M et al (2014) Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. Biol Blood Marrow Transplant. 20:272–278CrossRefPubMed Faraci M, Zecca M, Pillon M et al (2014) Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. Biol Blood Marrow Transplant. 20:272–278CrossRefPubMed
5.
go back to reference O’Brien TA, Eastlund T, Peters C et al (2004) Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 127(1):67–75CrossRefPubMed O’Brien TA, Eastlund T, Peters C et al (2004) Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 127(1):67–75CrossRefPubMed
6.
go back to reference Horn B, Viele M, Mentzer W et al (1999) Autoimmune hemolytic anemia in patients with SCID after T cell depleted BM and PBSC transplantation. Bone Marrow Transplant 24(9):1009–1013CrossRefPubMed Horn B, Viele M, Mentzer W et al (1999) Autoimmune hemolytic anemia in patients with SCID after T cell depleted BM and PBSC transplantation. Bone Marrow Transplant 24(9):1009–1013CrossRefPubMed
7.
go back to reference Leger RM (2014) The positive direct antiglobulin test and immune-mediated hemolysis. In: Fung MK, Grossman BJ, Hillyer CD, Westhoff CM (eds) Technical manual. AABB, Bethesda, pp 425–451 Leger RM (2014) The positive direct antiglobulin test and immune-mediated hemolysis. In: Fung MK, Grossman BJ, Hillyer CD, Westhoff CM (eds) Technical manual. AABB, Bethesda, pp 425–451
8.
go back to reference Judd WJ, Johnson S, Storry J (2008) Judd’s methods in immunohematology, 3rd edn. AABB Press, Bethesda, p 137 Judd WJ, Johnson S, Storry J (2008) Judd’s methods in immunohematology, 3rd edn. AABB Press, Bethesda, p 137
9.
go back to reference Daikeler T, Tyndall A (2007) Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 20:349–360CrossRefPubMed Daikeler T, Tyndall A (2007) Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 20:349–360CrossRefPubMed
10.
go back to reference Sherer Y, Shoenfeld Y (1998) Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 22:873–881CrossRefPubMed Sherer Y, Shoenfeld Y (1998) Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 22:873–881CrossRefPubMed
11.
go back to reference Raj A, Bertolone S, Cheerva A et al (2004) Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol 26(5):312–314CrossRefPubMed Raj A, Bertolone S, Cheerva A et al (2004) Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol 26(5):312–314CrossRefPubMed
Metadata
Title
Blood Group Discrepancy-First Sign of Autoimmune Hemolytic Anemia after Hematopoietic Stem Cell Transplantation in a Child
Authors
Suvro Sankha Datta
Mahua Reddy
Sabita Basu
Shekhar Krishnan
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0630-2

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine